Tuesday, March 24th 2020 at 11:00am UTC Collaboration between Triumvira Immunologics and Lonza will leverage the innovative Cocoon® Platform for…
Tuesday, March 17th 2020 at 3:31pm UTC Le protocole de soins de compassion sera mené au Rambam Healthcare Campus en…
Friday, March 27th 2020 at 10:04pm UTC VANCOUVER, B.C.–(BUSINESS WIRE)– As COVID-19 places a strain on urgent patient care and…
Wednesday, March 18th 2020 at 12:23pm UTC DARTMOUTH, Nova Scotia–(BUSINESS WIRE)– IMV Inc. (TSX: IMV; NASDAQ: IMV) (the « Company » or…
Wednesday, March 25th 2020 at 7:00pm UTC TORONTO–(BUSINESS WIRE)– Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”) today provides…
Tuesday, March 17th 2020 at 10:45am UTC OTTAWA, Ontario–(BUSINESS WIRE)– Avivagen Inc. (TSXV:VIV) (“Avivagen”), a life sciences corporation focused on…
Wednesday, March 25th 2020 at 6:07pm UTC – BELLUS now owns 100% of BLU-5937 and related P2X3 antagonist intellectual property…
Wednesday, March 25th 2020 at 10:45am UTC OTTAWA, Ontario–(BUSINESS WIRE)– Avivagen Inc. (TSXV:VIV) “Avivagen”), a life sciences corporation focused on…
Tuesday, March 24th 2020 at 9:00pm UTC VANCOUVER, British Columbia–(BUSINESS WIRE)– Canada’s largest biotechnology company, Vancouver’s STEMCELL Technologies, has been…
Monday, March 23rd 2020 at 11:31am UTC – BELLUS to own 100% of BLU-5937 and related P2X3 antagonists intellectual property…